Principal Investigator: Matt Harms, MD
Project Duration: 3 years
- Aim 1: Identify and prospectively phenotype 1500 ALS/MND patients with paired DNA, RNA and iPSC-ready PBMC samples.
- Aim 2: Generate, annotate, and analyze whole-genome and RNA sequencing for 1500 ALS/MND patients.
- Aim 3: Integrate whole-genome sequence data with RNA-seq derived transcriptome data and clinical phenotypes for 1500 ALS/MND patients.
How CIB accelerates this project:
CIB operates as the data coordination core.
Platforms used: NeuroBANK™, NeuroGUID